• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里敲除小鼠的神经生理学、行为学和形态学异常。

Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.

作者信息

Rodrigues L G, Ferraz M J, Rodrigues D, Pais-Vieira M, Lima D, Brady R O, Sousa M M, Sá-Miranda M C

机构信息

Lysosome and Peroxisome Biology Unit, Instituto de Biologia Molecular e Celular, Porto, Portugal.

出版信息

Neurobiol Dis. 2009 Jan;33(1):48-56. doi: 10.1016/j.nbd.2008.09.001. Epub 2008 Sep 23.

DOI:10.1016/j.nbd.2008.09.001
PMID:18848893
Abstract

Fabry disease (OMIM 301500) is a rare X-linked recessive disorder caused by mutations in the alpha-galactosidase gene (GLA). Loss of alpha-galactosidase (alpha-Gal) activity leads to the abnormal accumulation of glycosphingolipids in lysosomes predominantly of vascular endothelial cells. Clinically the disorder presents with angiokeratomas, clouding of the cornea, and renal, cardiac, and cerebrovascular complications. In addition, there is an increased incidence of neuropathic pain in Fabry patients. In this study, we investigated the implications of loss of alpha-galactosidase A activity on sensorimotor function and peripheral nervous system. Similar to the described in Fabry disease patients, the sensorimotor assessment of Fabry mice revealed diminished locomotor activity and warm hypoalgesia as assessed in the hot-plate. Moreover Fabry mice displayed alterations both in balance and co-ordination. By histological analysis, the cyto-architecture of Fabry mice sciatic nerves showed an increase in mean cross-sectional area accompanied by a decrease in the density of non-myelinated fibers as well as a trend for a decreased number of small myelinated fibers, a well established feature of Fabry disease. A relative preservation of large myelinated fibers and nerve conduction velocity measurements was observed. Our findings demonstrate for the first time that Fabry knockout mice have Gb3 accumulation in the peripheral nervous system, alterations in sensorimotor function, hypoalgesia and no impairment of motor nerve conduction.

摘要

法布里病(OMIM 301500)是一种罕见的X连锁隐性疾病,由α-半乳糖苷酶基因(GLA)突变引起。α-半乳糖苷酶(α-Gal)活性丧失导致糖鞘脂在主要为血管内皮细胞的溶酶体中异常蓄积。临床上,该疾病表现为血管角质瘤、角膜混浊以及肾脏、心脏和脑血管并发症。此外,法布里病患者的神经性疼痛发病率增加。在本研究中,我们调查了α-半乳糖苷酶A活性丧失对感觉运动功能和周围神经系统的影响。与法布里病患者的描述相似,对法布里小鼠的感觉运动评估显示,如在热板试验中所评估的,运动活动减少和热感觉减退。此外,法布里小鼠在平衡和协调方面也表现出改变。通过组织学分析,法布里小鼠坐骨神经的细胞结构显示平均横截面积增加,同时无髓纤维密度降低,以及小的有髓纤维数量减少的趋势,这是法布里病的一个既定特征。观察到大型有髓纤维和神经传导速度测量相对保留。我们的研究结果首次证明,法布里基因敲除小鼠在外周神经系统中有Gb3蓄积,并存在感觉运动功能改变、感觉减退且运动神经传导未受损。

相似文献

1
Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.法布里敲除小鼠的神经生理学、行为学和形态学异常。
Neurobiol Dis. 2009 Jan;33(1):48-56. doi: 10.1016/j.nbd.2008.09.001. Epub 2008 Sep 23.
2
Normal hearing in alpha-galactosidase A-deficient mice, the mouse model for Fabry disease.α-半乳糖苷酶A缺乏小鼠(法布里病的小鼠模型)的正常听力。
Hear Res. 2007 Dec;234(1-2):10-4. doi: 10.1016/j.heares.2007.08.009. Epub 2007 Sep 14.
3
An in vitro model of Fabry disease.法布里病的体外模型。
J Am Soc Nephrol. 2005 Sep;16(9):2636-45. doi: 10.1681/ASN.2005040383. Epub 2005 Jul 20.
4
Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.法布里病杂合子患者的神经纤维功能和结构研究结果
Pain. 2009 Sep;145(1-2):237-45. doi: 10.1016/j.pain.2009.06.032. Epub 2009 Aug 7.
5
Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.酶替代疗法可改善法布里病患者的周围神经和汗腺功能。
Muscle Nerve. 2003 Dec;28(6):703-10. doi: 10.1002/mus.10497.
6
Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer.通过腺相关病毒介导的肌肉定向基因转移对敲除小鼠进行法布里病的长期全身治疗。
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13777-82. doi: 10.1073/pnas.222221899. Epub 2002 Oct 7.
7
Alpha-galactosidase A in vascular disease.血管疾病中的α-半乳糖苷酶A
Trends Cardiovasc Med. 2007 May;17(4):129-33. doi: 10.1016/j.tcm.2007.02.006.
8
Fabry disease.法布里病
Pharmacol Ther. 2009 Apr;122(1):65-77. doi: 10.1016/j.pharmthera.2009.01.003. Epub 2009 Feb 8.
9
Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.使用合成载体部分纠正法布里小鼠中α-半乳糖苷酶A缺乏并减少糖脂蓄积
J Gene Med. 2004 Jan;6(1):85-92. doi: 10.1002/jgm.468.
10
Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells.接受转导骨髓细胞的原发性和继发性移植法布里小鼠多个器官的长期酶校正和脂质减少。
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7515-20. doi: 10.1073/pnas.120177997.

引用本文的文献

1
ASIC1a-associated mechanical hypersensitivity in the GlaKO Fabry disease mouse model.GlaKO法布里病小鼠模型中与ASIC1a相关的机械性超敏反应
Neurobiol Pain. 2025 Jun 26;18:100189. doi: 10.1016/j.ynpai.2025.100189. eCollection 2025 Jul-Dec.
2
Age-related neuroimmune signatures in dorsal root ganglia of a Fabry disease mouse model.法布里病小鼠模型背根神经节中与年龄相关的神经免疫特征
Immun Ageing. 2023 May 12;20(1):22. doi: 10.1186/s12979-023-00346-8.
3
Fabry Disease and Central Nervous System Involvement: From Big to Small, from Brain to Synapse.
法布里病与中枢神经系统受累:从大到小,从脑到突触。
Int J Mol Sci. 2023 Mar 9;24(6):5246. doi: 10.3390/ijms24065246.
4
L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors.L-乙酰左卡尼汀通过上调 2 型代谢型谷氨酸受体在法布里病模型小鼠中引起镇痛作用。
Mol Pain. 2022 Jan-Dec;18:17448069221087033. doi: 10.1177/17448069221087033.
5
Ion channels and pain in Fabry disease.离子通道与法布瑞氏病的疼痛。
Mol Pain. 2021 Jan-Dec;17:17448069211033172. doi: 10.1177/17448069211033172.
6
Current and experimental therapeutics for Fabry disease.用于法布瑞氏病的现有治疗方法和实验性疗法。
Clin Genet. 2021 Sep;100(3):239-247. doi: 10.1111/cge.13999. Epub 2021 May 25.
7
Systemic Treatment of Fabry Disease Using a Novel AAV9 Vector Expressing α-Galactosidase A.使用表达α-半乳糖苷酶A的新型腺相关病毒9型载体对法布里病进行全身治疗。
Mol Ther Methods Clin Dev. 2020 Oct 22;20:1-17. doi: 10.1016/j.omtm.2020.10.016. eCollection 2021 Mar 12.
8
Fabry disease pain: patient and preclinical parallels.法布瑞氏病疼痛:患者和临床前的相似之处。
Pain. 2021 May 1;162(5):1305-1321. doi: 10.1097/j.pain.0000000000002152.
9
Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model.评估糖鞘脂在法布里病小鼠模型表型严重程度中的作用。
J Lipid Res. 2020 Nov;61(11):1410-1423. doi: 10.1194/jlr.RA120000909. Epub 2020 Aug 31.
10
Progress in the understanding and treatment of Fabry disease.法布瑞氏病的研究进展与治疗。
Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129437. doi: 10.1016/j.bbagen.2019.129437. Epub 2019 Sep 14.